Piramal Pharma (PPLPHARMA) Share Price falls 2.16% to Rs 205.65
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
Piramal Pharma Share Pricefell to Rs 205.65 on 28 September 2026, down 2.16% from the previous close, with market capitalisation at Rs 27,984.94 Cr. The supplied data does not point to a company-specific catalyst, so the move is best understood through verified price action, valuation and sector context. For readers tracking Piramal Pharma Share Price Today, the stock traded within a narrow band and ended close to the session low. Univest tracks this kind of stock news with facts first, helping readers separate recorded market movement from speculation.
Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 205.65 |
| Previous Close | Rs 210.2 |
| Today's Move | -Rs 4.55 (-2.16%) |
| Open | Rs 209.3 |
| High | Rs 212.3 |
| Low | Rs 205.25 |
| Turnover | Rs 3.27 crore |
| Market Capitalisation | Rs 27,984.94 crore |
| Market Cap Category | Large Cap |
Piramal Pharma Share Price Today closed at Rs 205.65 versus the previous close of Rs 210.2, a decline of Rs 4.55 or 2.16%. The stock opened at Rs 209.3, touched an intraday high of Rs 212.3 and a low of Rs 205.25, which places the close near the day’s low. Turnover stood at Rs 3.27 crore. The company is classified as a Large Cap in the supplied data, with market capitalisation of Rs 27,984.94 Cr. That size context is factual, but it does not explain the day’s move on its own.
The day’s range of Rs 205.25 to Rs 212.3 shows a Rs 7.05 spread between low and high. Because the stock ended close to the low, the Piramal Pharma Share Price story is mostly about the final session outcome rather than any supplied trigger. Readers searching Piramal Pharma Stock Falling Today or Piramal Pharma Share Price Fall will find the verified facts here without added interpretation.
Piramal Pharma (PPLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 27,984.94 crore |
| P/B Ratio | 3.5x |
| ROE | -4.04% |
| ROCE | 1.24% |
| EPS | Rs -2.36 |
| Book Value Per Share | Rs 60.13 |
| Dividend Yield | 0% |
Piramal Pharma Share Price News becomes more meaningful when set against the company’s fundamentals. The stock has a P/B ratio of 3.5, book value of Rs 60.13 per share and a dividend yield of 0. EPS is negative at Rs -2.36, ROE is -4.04% and ROCE is 1.24%, which together show that earnings and return measures are under pressure in the supplied figures. These are important context points for anyone reviewing Piramal Pharma Fundamental Analysis, even though they do not identify a fresh trigger for the decline.
The market cap of Rs 27,984.94 Cr is much larger than the book value per share, so valuation and profitability should be checked together rather than in isolation. That is why the Piramal Pharma Share Price decline should be read alongside the stock’s return profile and not as a standalone number. Univest presents this structure to keep the discussion grounded in the available data.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 49.63x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 3.5x |
| Benchmark Median P/B | 2.85x |
| Benchmark Average P/B | 4.33x |
| Company ROE | -4.04% |
| Benchmark Median ROE | 11.48% |
| Benchmark Average ROE | 10.04% |
| Company ROCE | 1.24% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.82% |
| Company Market Capitalisation | Rs 27,984.94 crore |
| Benchmark Median Market Cap | Rs 732.57 crore |
| Benchmark Average Market Cap | Rs 14,043.26 crore |
Piramal Pharma Share Price sits within Healthcare and the Pharmaceuticals & Drugs industry, where the same-industry benchmark covers 204 companies. The company’s P/B of 3.5 is above the sector median of 2.85 and below the sector average of 4.33. Its ROE of -4.04% is below the sector median of 11.48% and average of 10.04%, while ROCE of 1.24% is also below the sector median of 13.17% and average of 12.82%.
The benchmark market-cap median is Rs 732.57 Cr and the average is Rs 14,043.26 Cr, while Piramal Pharma’s market cap is Rs 27,984.94 Cr. That places the stock above both benchmark size measures. The industry data also shows wide dispersion, with market caps ranging from Rs 3.98 Cr to Rs 444,716.74 Cr. For readers reviewing Piramal Pharma Stock Analysis, the key factual takeaway is simple: the company is larger than the benchmark center of gravity, but its return metrics remain below the same industry’s median and average levels.
The same industry benchmark shows a P/B range from -22.29 to 35.45, which underlines how varied the sector can be. Even so, the relevant comparison remains straightforward: Piramal Pharma Share Price is supported by a mid-range P/B, but the return ratios are weaker than the benchmark norms.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,44,716.74 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,55,115.31 | 87.22 | 14.44 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,613.38 | 86.94 | 21.13 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,899.96 | 26.57 | 4.45 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,875.68 | 33.49 | 3.21 | 11.83 | 16 |
Among the supplied peers, Piramal Pharma Share Price stands out more for its scale than for its return ratios. Its market cap of Rs 27,984.94 Cr is smaller than each listed peer in the comparison set. On valuation, the stock’s P/B of 3.5 is lower than Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals and Zydus Lifesciences, but higher than Cipla. On profitability, ROE at -4.04% and ROCE at 1.24% are below every peer supplied here.
That makes the peer comparison useful for Piramal Pharma Share Price News because it shows a company that is sizeable, but still lagging the listed comparators on return measures. Univest uses this comparison so readers can assess the stock in a broader industry context instead of viewing the day’s move in isolation.
Why Investors Are Watching Piramal Pharma
- Piramal Pharma Share Price fell 2.16% to Rs 205.65 from Rs 210.2.
- The day’s range was Rs 205.25 to Rs 212.3, with turnover of Rs 3.27 Cr.
- Market capitalisation stands at Rs 27,984.94 Cr and the company is tagged as Large Cap.
- P/B is 3.5, EPS is Rs -2.36, ROE is -4.04% and ROCE is 1.24%.
About Piramal Pharma
Piramal Pharma operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied profile identifies the stock on NSE and BSE through the symbol PPLPHARMA. In this dataset, the key company facts available for Piramal Pharma Stock News are market capitalisation, valuation, profitability and the listed price move. For investors reading Piramal Pharma Company News, the most relevant verified context is that the business sits within a sector where valuation and return metrics vary widely across peers.
The company’s current numbers also show a book value of Rs 60.13 per share and a dividend yield of 0. Those are simple reference points for Piramal Pharma Share Price Today because they show the accounting base and payout context without adding an unsupported narrative. If you are following Piramal Pharma Latest News, the focus should remain on verified financial facts and the daily share price fall already recorded here.
Track Piramal Pharma Share Price on Univest
Use Piramal Pharma (PPLPHARMA) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.
On Univest, readers can track Piramal Pharma Share Price Live alongside company fundamentals, shareholding pattern, market insights and historical price levels. The platform also helps users follow Piramal Pharma Stock Analysis, Piramal Pharma Share Price Update and broader Piramal Pharma Stock News in one place. For a stock that moved today, the most useful next step is to watch the same verified data series rather than rely on speculation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Piramal Pharma Share Price fall today?
Ans. The supplied data shows Piramal Pharma Share Price fell 2.16% to Rs 205.65. It does not establish a company-specific catalyst, so the move should be read as verified price action only.
What is Piramal Pharma Share Price Today?
Ans. Piramal Pharma Share Price Today is Rs 205.65, compared with the previous close of Rs 210.2. The stock moved between Rs 205.25 and Rs 212.3 during the session. The previous close was Rs 210.2.
What is the market capitalisation of Piramal Pharma?
Ans. Piramal Pharma has a market capitalisation of Rs 27,984.94 Cr. The data also tags the company as Large Cap, which is a factual size classification in the supplied dataset. The company operates in the Healthcare sector.
How does Piramal Pharma compare with its sector benchmark?
Ans. In the same industry benchmark, Piramal Pharma's P/B of 3.5 is above the median of 2.85 but below the average of 4.33. Its ROE and ROCE are below the sector median and average.
What do Piramal Pharma's EPS and ROE show?
Ans. Piramal Pharma reports EPS of Rs -2.36 and ROE of -4.04%. Those figures indicate negative earnings per share and negative return on equity in the supplied data. ROE stands at -4.04%.
How does Piramal Pharma look versus listed peers?
Ans. Piramal Pharma's market cap is below every listed peer in the supplied set, while its ROE and ROCE are also below all of them. That makes the peer comparison especially relevant.
What is Piramal Pharma's book value and dividend yield?
Ans. Book value is Rs 60.13 per share and dividend yield is 0. These two numbers help frame the Piramal Pharma Share Price as an accounting and payout comparison point, not a forecast.
